Integration of microRNAome, proteomics and metabolomics to analyze arsenic-induced malignant cell transformation

Youyou Zhou1, Yanfu Wang2, Juan Su1

  • 1Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.

Oncotarget
|December 7, 2017
PubMed

Insights

Arsenic exposure can cause skin cancer through unclear mechanisms. This study used multi-omics to reveal altered microRNA, protein, and metabolite profiles in arsenic-transformed cells, identifying potential early biomarkers for skin cancer.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Biochemistry

Background:

  • Long-term arsenic exposure is linked to tumorigenesis, particularly in skin.
  • The precise molecular mechanisms underlying arsenic-induced carcinogenesis remain largely unknown.

Purpose of the Study:

  • To investigate the molecular mechanisms of arsenic-induced cell malignant transformation.
  • To identify potential early biomarkers for arsenic-induced cutaneous squamous cell carcinoma.

Main Methods:

  • Integrated multi-omics analysis: microRNAome, proteomics, and metabolomics.
  • Utilized Q-RT-PCR, 2D-PAGE, mass spectrometry (MS), and UPLC/Q-TOF MS.
  • Compared non-malignant human keratinocytes (HaCaT) with arsenic-induced transformed cells.

Main Results:

  • Identified 26 significantly altered microRNAs (miRNAs), with 6 confirmed via Q-RT-PCR, linked to oxidative stress.
  • Detected 12 differentially expressed proteins, including heat shock protein beta-1 (HSPB1) and peroxiredoxin-2 (PRDX2), associated with oxidative stress and carcinogenesis.
  • Quantified 68 metabolites related to redox, glutathione, citrate, and amino acid metabolism.

Conclusions:

  • Arsenic-induced transformed cells display distinct miRNA, protein, and metabolite profiles.
  • These alterations provide novel insights into arsenic-induced cell transformation.
  • The identified molecular changes may serve as early potential biomarkers for arsenic-induced cutaneous squamous cell carcinoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K